Form 4 for CDW CDW Corporation
Accepted 2023-11-17 00:00:00 ET · period of report 2023-11-15 · accession 0001402057-23-000171 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-11-17 | 2023-11-15+ | CDW | LEAHY CHRISTINE A | See Remarks, Dir | M - OptEx | $39.11 | +51.4K | 71.0K | +262% | +$2.01M |
| DM | 2023-11-17 | 2023-11-15 | CDW | LEAHY CHRISTINE A | See Remarks, Dir | S - Sale+OE | $218.81 | -44.4K | 68.6K | -39% | -$9.71M |
| DM | 2023-11-17 | 2023-11-15+ | CDW | LEAHY CHRISTINE A | See Remarks, Dir | M - OptEx | $0.00 | -51.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.01 | 2023-11-15 | M | A | 29,293 | $39.79 | 113,004.96 | D | — | — | |
| 2 | Common | Common Stock, par value $0.01 | 2023-11-15 | M | A | 15,090 | $37.79 | 83,711.96 | D | — | — | |
| 3 | Common | Common Stock, par value $0.01 | 2023-11-16 | M | A | 4,635 | $39.79 | 75,675.96 | D | — | — | (F5) The shares acquired upon the exercise of stock options on November 16, 2023 are being held by Ms. Leahy. |
| 4 | Common | Common Stock, par value $0.01 | 2023-11-16 | M | A | 2,419 | $37.79 | 71,040.96 | D | — | — | (F5) The shares acquired upon the exercise of stock options on November 16, 2023 are being held by Ms. Leahy. |
| 5 | Common | Common Stock, par value $0.01 | 2023-11-15 | S | D | 3,737 | $217.87 | 109,267.96 | D | — | — | (F1) On August 7, 2023, the reporting person adopted a Rule 10b5-1 trading plan that is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. This plan provides for the exercise of stock options and sale of up to an aggregate of 51,437 underlying shares of common stock of the Issuer during the period from November 15, 2023 through April 30, 2024. (F2) The price reported is the average weighted price. The shares were sold in multiple transactions at prices ranging from $217.22 to $218.21, inclusive. The reporting person undertakes to provide to the SEC, the Issuer and any security holder, the full information regarding the number of shares and the prices at which the shares were sold. |
| 6 | Common | Common Stock, par value $0.01 | 2023-11-15 | S | D | 35,943 | $218.83 | 73,324.96 | D | — | — | (F1) On August 7, 2023, the reporting person adopted a Rule 10b5-1 trading plan that is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. This plan provides for the exercise of stock options and sale of up to an aggregate of 51,437 underlying shares of common stock of the Issuer during the period from November 15, 2023 through April 30, 2024. (F3) The price reported is the average weighted price. The shares were sold in multiple transactions at prices ranging from $218.22 to $219.21, inclusive. The reporting person undertakes to provide to the SEC, the Issuer and any security holder, the full information regarding the number of shares and the prices at which the shares were sold. |
| 7 | Common | Common Stock, par value $0.01 | 2023-11-15 | S | D | 4,703 | $219.45 | 68,621.96 | D | — | — | (F1) On August 7, 2023, the reporting person adopted a Rule 10b5-1 trading plan that is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. This plan provides for the exercise of stock options and sale of up to an aggregate of 51,437 underlying shares of common stock of the Issuer during the period from November 15, 2023 through April 30, 2024. (F4) The price reported is the average weighted price. The shares were sold in multiple transactions at prices ranging from $219.215 to $219.71 , inclusive. The reporting person undertakes to provide to the SEC, the Issuer and any security holder, the full information regarding the number of shares and the prices at which the shares were sold. |
| 8 | Derivative | Employee Stock Option (Right to Buy) | 2023-11-16 | M | D | 4,635 | $0.00 | 0 | D | $39.79 · — to 2026-03-02 | 4,635 Common Stock, par value $0.01 | (F8) 33,928 options were granted of which one third of the shares vested on each of March 2, 2017, 2018 and 2019. The grant was made under the CDW Corporation Long-Term Incentive Plan. |
| 9 | Derivative | Employee Stock Option (Right to Buy) | 2023-11-15 | M | D | 29,293 | $0.00 | 4,635 | D | $39.79 · — to 2026-03-02 | 29,293 Common Stock, par value $0.01 | (F8) 33,928 options were granted of which one third of the shares vested on each of March 2, 2017, 2018 and 2019. The grant was made under the CDW Corporation Long-Term Incentive Plan. |
| 10 | Derivative | Employee Stock Option (Right to Buy) | 2023-11-15 | M | D | 15,090 | $0.00 | 2,419 | D | $37.79 · — to 2025-02-19 | 15,090 Common Stock, par value $0.01 | (F7) 31,754 options were granted of which one third of the shares vested on each of February 19, 2016, 2017 and 2018. The grant was made under the CDW Corporation Long-Term Incentive Plan. |
| 11 | Derivative | Employee Stock Option (Right to Buy) | 2023-11-16 | M | D | 2,419 | $0.00 | 0 | D | $37.79 · — to 2025-02-19 | 2,419 Common Stock, par value $0.01 | (F7) 31,754 options were granted of which one third of the shares vested on each of February 19, 2016, 2017 and 2018. The grant was made under the CDW Corporation Long-Term Incentive Plan. |